Comparing Different Methods for the Diagnosis of Liver Steatosis: What Are the Best Diagnostic Tools?
Authors:
- Sophie ChopinetSCSophie Chopinet
- Olivier LopezOLOlivier Lopez
- Sophie BrustleinSBSophie Brustlein
- Antoine UzelAUAntoine Uzel
- Anais MoyonAMAnais Moyon
- Isabelle VarletIVIsabelle Varlet
- Laure BalasseLBLaure Balasse
- Frank KoberFKFrank Kober
- Mickaël BobotMBMickaël Bobot
- Monique BernardMBMonique Bernard
- Aurélie HaffnerAHAurélie Haffner
- Michaël SdikaMSMichaël Sdika
Open Access
- 16 October 2024
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 14 (20) , 2292
Abstract
Background: Due to the ongoing organ shortage, marginal grafts with steatosis are more frequently used in liver transplantation, leading to higher occurrences of graft dysfunction. A histological analysis is the gold standard for the quantification of liver steatosis (LS), but has its drawbacks: it is an invasive method that varies from one pathologist to another and is not available in every hospital at the time of organ procurement. This study aimed to compare non-invasive diagnostic tools to a histological analysis for the quantification of liver steatosis. Methods: Male C57BL6J mice were fed with a methioninecholine-deficient (MCD) diet for 14 days or 28 days to induce LS, and were compared to a control group of animals fed with a normal diet. The following non-invasive techniques were performed and compared to the histological quantification of liver steatosis: magnetic resonance spectroscopy (MRS), CARS microscopy, 99mTc MIBI SPECT imaging, and a new near-infrared spectrometer (NIR-SG1). Results: After 28 days on the MCD diet, an evaluation of LS showed ≥30% macrovesicular steatosis. High correlations were found between the NIR-SG1 and the blinded pathologist analysis (R2 = 0.945) (p = 0.001), and between the CARS microscopy (R2 = 0.801 (p < 0.001); MRS, R2 = 0.898 (p < 0.001)) and the blinded pathologist analysis. The ROC curve analysis showed that the area under the curve (AUC) was 1 for both the NIR-SG1 and MRS (p = 0.021 and p < 0.001, respectively), while the AUC = 0.910 for the Oil Red O stain (p < 0.001) and the AUC = 0.865 for the CARS microscopy (p < 0.001). The AUC for the 99mTc MIBI SPECT was 0.640 (p = 0.013), and this was a less discriminating technique for LS quantification. Conclusions: The best-performing non-invasive methods for LS quantification are MRS, CARS microscopy, and the NIR-SG1. The NIR-SG1 is particularly appropriate for clinical practice and needs to be validated by clinical studies on liver grafts.Keywords
Funding Information
- Marseille Imaging Institute (AMX-19-IET-002)
This publication has 32 references indexed in Scilit:
- Dual-energy CT in diffuse liver disease: is there a role?Abdominal Radiology, 2020
- Quantification of steatosis in alcoholic and nonalcoholic fatty liver disease: Evaluation of four MR techniques versus biopsyEuropean Journal of Radiology, 2019
- Prediction of nonalcoholic fatty liver disease (NAFLD) activity score (NAS) with multiparametric hepatic magnetic resonance imaging and elastographyEuropean Radiology, 2019
- Intraoperative liver steatosis characterization using diffuse reflectance spectroscopyHPB, 2019
- The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan®Clinics and Research in Hepatology and Gastroenterology, 2012
- Spectroscopie par résonance magnétique : le nouveau standard pour quantifier la stéatose hépatique ?Gastroentérologie Clinique Et Biologique, 2009
- Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best?Clinical Imaging, 2009
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisHepatology, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retentionEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993